Pediatric anesthesia & critical care

The use of intranasal sufentanil and/or s‐ketamine for treatment of procedural pain in children in an ambulatory setting: A retrospective observational study

Acta Anaesthesiol ScandPublished Retrospective observational study

Authors' conclusion

Intranasal sufentanil and/or s-ketamine are feasible for the treatment of procedural pain in an ambulatory setting with appropriate per- and post-procedural observations and trained staff.

Study context

Population
Children 1 year up till 18 years undergoing painful medical procedures outside the operating room, tertiary care paediatric hospitalmedical procedures, 2004–2014
Participants
2,185 children
Exposure
Intranasal sufentanil vs s-ketamine vs free combination
Outcome
Frequency of adverse events including serious adverse events, by intervention
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Procedures with at least one adverse event
Common adverse events: vomiting
9%
Common adverse events: nausea
8%
Common adverse events: dizziness
3%
Serious adverse events in intranasal (IN) S (1 respiratory depression and bronchospasm; 1 seizure in a patient with cerebral palsy), handled immediately, no sequelae
2

Observational data: associations, not effects.

Secondary outcomes

Median, μg/kg

OutcomeIN SKIN S
Intranasal sufentanil dose0.5 (range 0.2–1.3)0.8 (range 0.2–2.7)
Intranasal sufentanil dose — Median sufentanil dose lower when combined with s-ketamine
38%
  • Intranasal sufentanil dose: s-ketamine dose in IN SK 0.5 mg/kg (range 0.2-1.5)

Analgesic effect

Similar analgesic effect for S and SK

Safety

Serious adverse events — IN S
2 events

Serious adverse events

Respiratory depression and bronchospasm (1); seizure in cerebral palsy (1); no sequelae

Original publication

The use of intranasal sufentanil and/or s‐ketamine for treatment of procedural pain in children in an ambulatory setting: A retrospective observational study. Acta Anaesthesiol Scand. Published 18 August 2024. doi:10.1111/aas.14510

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.